Alyeska Investment Group
GRTS

Alyeska Investment Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Alyeska Investment Group’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,461,489
Closed -$2.14M – 730
2024
Q2 		$2.14M Buy
+3,461,489
New +$2.92M 0.01% 407
2018
Q4 		– Sell
-113,300
Closed -$1.61M – 482
2018
Q3 		$1.61M Buy
+113,300
New +$1.61M 0.02% 317

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Alyeska Investment Group's GRTS Position: Q3 2024 in Review

Alyeska Investment Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 3,461,489 shares — an estimated $2.14M sold.

Alyeska Investment Group first reported a position in GRTS in Q3 2018 and held it in 2 quarters. The position peaked at $2.14M in Q2 2024. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Alyeska Investment Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 3,461,489 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $2.14M.
  • Alyeska Investment Group first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Alyeska Investment Group's Gritstone bio, Inc. Common Stock position peaked at $2.14M in Q2 2024.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Alyeska Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.